Two gut bacteria together suppressed Clostridioides difficile across strains.

Patient data showed the Bacteroides-to-Escherichia ratio predicted resistance better than standard diversity metrics.

Fructan-derived sugars, vitamin B3 synthesis and competition for Stickland metabolism precursors drive the suppression, experiments showed.

The study did not test a Bacteroides-Escherichia therapy in patients.

Sources: Nature Communications